SAMANTHA ECKBURG: Open Payments
NPI 1679128730 · ROCKFORD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$145 in 8 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $145
Food & beverage: $145
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
| Orexo US, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: CAPLYTA, Zubsolv, INVEGA SUSTENNA, TRINTELLIX, ABILIFY ASIMTUFII, INGREZZA, SPRAVATO.
Industry payments across IL — which companies pay providers there.
